scispace - formally typeset
R

Richard F. Spaide

Researcher at Manhattan Eye, Ear and Throat Hospital

Publications -  444
Citations -  42209

Richard F. Spaide is an academic researcher from Manhattan Eye, Ear and Throat Hospital. The author has contributed to research in topics: Macular degeneration & Fluorescein angiography. The author has an hindex of 98, co-authored 422 publications receiving 36946 citations. Previous affiliations of Richard F. Spaide include University of Illinois at Chicago & Landstuhl Regional Medical Center.

Papers
More filters
Journal ArticleDOI

Vitrectomy with Inner Retinal Fenestration for Optic Disc Pit Maculopathy

TL;DR: The introduction of a partial thickness fenestration radial to the optic disc pit was associated with retinal anatomic and functional improvement without additional treatments, consistent with the hypothesis that redirection of flow to allow egress of fluid into the vitreous cavity instead of into the retina can achieve long-lasting amelioration of the pathologic findings of optic pit maculopathy.
Journal ArticleDOI

Lipid Hydroperoxide Stimulates Subretinal Choroidal Neovascularization in the Rabbit

TL;DR: Subretinal injection of LHP is capable of inducing CNV and exposed areas turned white as observed ophthalmoscopically and showed both severe retinal and choroidal atrophy histologically.
Journal ArticleDOI

Intravitreal cellular infiltrate imaged as punctate spots by spectral-domain optical coherence tomography in eyes with posterior segment inflammatory disease.

TL;DR: The posterior segment in cases of clinically evident intraocular inflammation for punctate reflections consistent with that expected to arise from inflammatory cells is investigated in patients with ocular inflammatory diseases imaged with spectral-domain optical coherence tomography (SD-OCT).
Journal ArticleDOI

Long-term outcomes of intravitreal antivascular endothelial growth factor therapy for the management of choroidal neovascularization in pseudoxanthoma elasticum.

TL;DR: These long-term results support the use of intravitreal antivascular endothelial growth factor therapy for the management of choroidal neovascularization in patients with pseudoxanthoma elasticum.